IMRN Immuron Limited
Price Chart
Executive Summary
Immuron Limited reported unaudited Q3 sales of AUD$1.5 million, up 16% year-over-year, driven by strong growth in Australia and Canada, with U.S. sales flat. Full financial results including EPS were not disclosed.
Actionable Insight
Monitor next 10-Q for GAAP financials to confirm if revenue growth is translating into margin expansion. Canada's rapid uptake could signal scalable international distribution.
Key Facts
- Q3 global sales: AUD$1.5 million (+16% YoY)
- Australia Q3 sales: AUD$0.9 million (+15% YoY)
- Canada Q3 sales: AUD$0.1 million (+82% QoQ, >100% YoY)
- USA Q3 sales: AUD$0.5 million (+1% YoY)
- YTD sales: AUD$5.7 million (+7% YoY)
- No EPS or profitability data disclosed
Financial Impact
Sales growth of 16% YoY to AUD$1.5 million (~$1.02M USD), with Canada showing explosive sequential growth
Risk Factors
- Currency risk from AUD/USD exchange rate fluctuations
- Lack of disclosed profitability or EPS data limits fundamental assessment
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3276005 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 8, 2026
16d ago
|
6-K
| $0.8050 $1.11 | ▲ +37.89% | ▲ +36.42% | $1.00 (+24.22%) |
|
Apr 17, 2026
5w ago
|
Press Release
| $0.9580 $0.8940 | ▼ −6.68% | ▼ −7.24% | $1.00 (+4.38%) |
|
Apr 17, 2026
5w ago
|
6-K
| $0.9580 $0.8940 | ▼ −6.68% | ▼ −7.24% | $1.00 (+4.38%) |
|
Apr 13, 2026
5w ago
|
6-K
| $0.7860 $0.9580 | ▲ +21.88% | ▲ +18.59% | $1.00 (+27.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access